JP2019094268A - Undifferentiated state maintenance agent for hair follicle stem cells - Google Patents

Undifferentiated state maintenance agent for hair follicle stem cells Download PDF

Info

Publication number
JP2019094268A
JP2019094268A JP2017222047A JP2017222047A JP2019094268A JP 2019094268 A JP2019094268 A JP 2019094268A JP 2017222047 A JP2017222047 A JP 2017222047A JP 2017222047 A JP2017222047 A JP 2017222047A JP 2019094268 A JP2019094268 A JP 2019094268A
Authority
JP
Japan
Prior art keywords
stem cells
ginseng
hair follicle
hair
follicle stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017222047A
Other languages
Japanese (ja)
Other versions
JP7089267B2 (en
Inventor
克真 宮地
Katsuma Miyachi
克真 宮地
貴亮 山田
Takaaki Yamada
貴亮 山田
悠 井上
Yu Inoue
悠 井上
靖司 長谷川
Yasushi Hasegawa
靖司 長谷川
修平 田所
Shuhei Tadokoro
修平 田所
坂井田 勉
Tsutomu Sakaida
勉 坂井田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Menard Cosmetic Co Ltd
Original Assignee
Nippon Menard Cosmetic Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Menard Cosmetic Co Ltd filed Critical Nippon Menard Cosmetic Co Ltd
Priority to JP2017222047A priority Critical patent/JP7089267B2/en
Publication of JP2019094268A publication Critical patent/JP2019094268A/en
Application granted granted Critical
Publication of JP7089267B2 publication Critical patent/JP7089267B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

To find a novel factor that can be easily introduced into a living body and maintain the function of hair follicle stem cells to provide as a drug for preventing and/or ameliorating hair loss fundamentally and efficiently.SOLUTION: The present invention provides an undifferentiated state maintenance agent for Hair follicle stem cells, a promotor for gene expression of extracellular matrix protein, an agent for preventing and/or improving alopecia, as well as a hair composition, which are characterized by containing heat-treated-Panax ginseng extract after a steam heating treatment as an active ingredient.SELECTED DRAWING: None

Description

本発明は、毛包幹細胞の未分化状態維持剤及びその使用に関する。   The present invention relates to an agent for maintaining undifferentiated state of hair follicle stem cells and use thereof.

近年、加齢、ストレス、紫外線等の様々な要因により、薄毛や脱毛といった毛髪のトラブルが増加している。毛髪は体表面を覆っており、皮膚の付属器官のひとつであり、毛髪の中でも頭髪は美容上極めて重要な要素である。よって、薄毛や脱毛は、心理面にもマイナスの影響を与え、生活の質(Quality of Life, QOL)を大きく低下させる要因となる(非特許文献1)。   In recent years, due to various factors such as aging, stress and ultraviolet rays, hair problems such as thinning and hair loss are increasing. Hair covers the body surface and is one of the appendages of the skin, and among the hair, hair is a very important cosmetic factor. Therefore, thinning hair and hair loss have a negative impact on the psychological aspect, and become a factor that greatly reduces the quality of life (Quality of Life, QOL) (Non-Patent Document 1).

毛髪は複数種の細胞からなる複雑な構造をとっているが、主にバルジ領域に存在する毛包幹細胞によって生み出されている。毛周期の休止期から成長期にかけて、このバルジ領域に存在する毛包幹細胞が、細胞分裂をすることで、毛母細胞が形成され、この毛母細胞から毛髪が形成される。   The hair has a complex structure consisting of multiple types of cells, but is mainly produced by hair follicle stem cells present in the bulge region. From the telogen to the growth phase of the hair cycle, hair follicle stem cells present in this bulge region undergo cell division to form hair mother cells, and hair mother cells are formed from the hair mother cells.

薄毛や脱毛の詳細なメカニズムは解明に至っていないが、最近の研究により、薄毛や脱毛などの症状は、毛包幹細胞が加齢によって老化し、自己複製能がなくなって、毛包の縮小が起こることや、毛包幹細胞が環境ストレス等によって長年ダメージを受け、機能低下や維持メカニズムが破綻することによって発生すると考えられている。また、近年では幹細胞の周囲の微細な環境(幹細胞ニッチ)に関しても研究が進められ、毛包組織周囲に存在する細胞外基質である17型コラーゲンが毛包幹細胞の機能維持において重要であることも明らかとなった(非特許文献2)。また、毛乳頭細胞から産生されるFGF2やFGF7は、毛髪の再生と恒常性維持に関与していることが知られている(非特許文献3)。   Although the detailed mechanism of thinning hair and hair loss has not been elucidated, recent research has shown that in conditions such as thinning hair and hair loss, hair follicle stem cells age with age, the ability to self-replicate is lost, and shrinkage of hair follicles occurs It is thought that hair follicle stem cells are damaged by environmental stress and the like for many years, resulting in failure of function or failure of maintenance mechanism. In recent years, research has also been conducted on the fine environment (stem cell niche) around stem cells, and it is also important that type 17 collagen, which is an extracellular matrix present around hair follicle tissue, is important in maintaining hair follicle stem cell function. It became clear (nonpatent literature 2). Furthermore, FGF2 and FGF7 produced from dermal papilla cells are known to be involved in hair regeneration and homeostasis maintenance (Non-patent Document 3).

よって、加齢等に伴う脱毛症状の改善のためには、毛髪の再生と恒常性維持を担っている毛包幹細胞の劣化を防ぎ、機能を回復させること、また、幹細胞の周囲の細胞外基質などの環境因子を正しく改善させることが重要であると考えられる。しかしながら、これまで報告されている上記因子は、生体内での制御や導入する手段が煩雑であるため日常的な使用が困難である。よって、これらに代わる新たな因子の解明が望まれる。   Therefore, for the amelioration of hair loss symptoms associated with aging etc., preventing the deterioration of hair follicle stem cells responsible for hair regeneration and homeostasis maintenance and restoring the function, and extracellular matrix around the stem cells It is considered important to properly improve environmental factors such as However, the above-described factors which have been reported so far are difficult to use on a daily basis because the means for control and introduction in vivo are complicated. Therefore, elucidation of new factors to replace them is desired.

オタネニンジン(学名:Panax ginseng C.A.Mey)は、ウコギ科トチバニンジン属に属する多年草であり、生薬の人参(ニンジン)は、オタネニンジンの根を乾燥させたもので、サポニンのジンセノサイドなどを含み、強壮、鎮静、抗疲労、強心、利尿等の作用を有する漢方薬に用いられている。人参(ニンジン)はまた、単独で又は他の植物抽出物と組み合わせて、血糖降下作用(特許文献1)、アンジオテンシンII活性阻害作用(特許文献2)などがあることが報告されている。しかしながら、毛包幹細胞の未分化維持効果についてはこれまで何ら知られていない。   Panax ginseng (Scientific name: Panax ginseng CAMey) is a perennial plant belonging to the genus Ekogidae Ginseng (carrot) is a dried ginseng root, which contains ginsenosides of saponin, etc., tonic, sedative, It is used in traditional Chinese medicine that has anti-fatigue, cardiac and diuretic effects. Ginseng (carrot) has also been reported to have hypoglycemic action (Patent Document 1), angiotensin II activity inhibitory action (Patent Document 2), etc. alone or in combination with other plant extracts. However, the undifferentiated maintenance effect of hair follicle stem cells has never been known so far.

特開平6−237735号公報Japanese Patent Application Laid-Open No. 6-237735 特開2013−119534号公報JP, 2013-119534, A

Sawant N et al., Androgenetic Alopecia: Quality-of-life and Associated Lifestyle Patterns, Int J Trichology. 2010 Jul;2(2):81-5Sawant N et al., Androgenetic Alopecia: Quality-of-life and Associated Lifestyle Patterns, Int J Trichology. 2010 Jul; 2 (2): 81-5 Matsumura H et al., Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016 Feb 5;351(6273)Matsumura H et al., Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis. Science. 2016 Feb 5; 351 (6273) Rosenquist TA et al., Fibroblast growth factor signalling in the hair growth cycle:expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle. Dev Dyn. 1996 Apr;205(4):379-86.Rosenquist TA et al., Fibroblast growth factor signaling in the hair growth cycle: expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle. Dev Dyn. 1996 Apr; 205 (4): 379-86.

本発明は、上述した実情に鑑み、生体内への導入が容易で、毛包幹細胞の機能を維持することができる新たな因子を見出し、脱毛症を根本的にかつ効率的に予防及び/又は改善するための薬剤として提供することを課題とする。   In view of the above-mentioned situation, the present invention finds a new factor which can be easily introduced into a living body and can maintain the function of hair follicle stem cells, and prevents and / or prevents alopecia fundamentally and / or efficiently. The task is to provide as a drug for improvement.

本発明者らは上記課題を解決すべく鋭意研究を重ねた結果、蒸気加熱処理後に加熱乾燥処理をするという前処理を行ってから抽出したオタネニンジンの抽出物が、毛包内バルジ領域に存在する毛包幹細胞の未分化状態を維持し、分化を抑制する作用を有すること、また、毛包幹細胞における細胞外基質タンパク質の遺伝子の発現促進作用を有することを見出した。よって、上記前処理を行ったオタネニンジンの抽出物は、毛髪を作り出す器官である毛包の供給源となる毛包幹細胞の減少又は枯渇を阻止できるとともに、毛包幹細胞周囲の細胞外環境を整えることができるので、脱毛症の根本的な予防及び/又は改善に有効である。本発明はかかる知見より完成されたものである。   As a result of intensive studies to solve the above problems, the present inventors have found that the extract of Ginseng extracted after being subjected to pretreatment such as heat drying after steam heat treatment is present in the bulge region of the hair follicle. It has been found that hair follicle stem cells are maintained in an undifferentiated state and have an action to suppress differentiation, and that they have an action to promote the expression of extracellular matrix protein gene in hair follicle stem cells. Therefore, the extract of ginseng treated with the above-mentioned pretreatment can prevent the loss or depletion of hair follicle stem cells serving as a source of hair follicles, which are organs producing hair, and adjust the extracellular environment around hair follicle stem cells. It is effective for radical prevention and / or amelioration of alopecia. The present invention has been completed based on such findings.

すなわち、本発明は、以下の発明を包含する。
(1)蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、幹細胞の未分化状態維持剤。
(2)前記幹細胞が、毛包幹細胞である、(1)に記載の幹細胞の未分化状態維持剤。
(3)蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、脱毛症の予防及び/又は改善剤。
(4)蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、細胞外基質タンパク質の遺伝子の発現促進剤。
(5)前記オタネニンジンが、乾燥又は生のオタネニンジンである、(1)〜(4)のいずれかに記載の剤。
(6)(3)に記載の脱毛症の予防及び/又は改善剤を含む、毛髪用組成物。
That is, the present invention includes the following inventions.
(1) An agent for maintaining an undifferentiated state of stem cells, which comprises as an active ingredient an extract of heat-treated dried ginseng after steam heat treatment.
(2) The agent for maintaining an undifferentiated state of stem cells according to (1), wherein the stem cells are hair follicle stem cells.
(3) A preventive and / or ameliorating agent for alopecia characterized by containing an extract of heat-dried treated ginseng as an active ingredient after steam heat treatment.
(4) An expression promoter for an extracellular matrix protein gene, which comprises as an active ingredient an extract of heat-dried ginseng after steam heat treatment.
(5) The agent in any one of (1)-(4) whose said ginseng is dried or raw ginseng.
(6) A composition for hair comprising the agent for preventing and / or ameliorating alopecia according to (3).

本発明によれば、蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有する毛包幹細胞の未分化状態維持剤、脱毛症の予防及び/又は改善剤が提供される。蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物は、毛包幹細胞の減少又は枯渇を阻止でき、また、毛包幹細胞の増殖と維持に必要な毛包幹細胞周囲の細胞外環境を整えることができるので、脱毛症の根本的な予防及び/又は改善に有効である。   According to the present invention, an agent for maintaining the undifferentiated state of hair follicle stem cells and an agent for preventing and / or improving alopecia, which comprise the extract of heat-dried treated ginseng as an active ingredient after steam heat treatment, are provided. After steam heat treatment, the heat-dried extract of ginseng can prevent the loss or depletion of hair follicle stem cells, and adjust the extracellular environment around hair follicle stem cells necessary for hair follicle stem cell growth and maintenance. It is effective for radical prevention and / or amelioration of alopecia.

本発明の幹細胞の未分化状態維持剤は、蒸気加熱処理後、加熱乾燥処理されたオタネニンジンを有効成分として含有する。本発明に係る幹細胞の未分化状態維持剤を、ヒトを含めた哺乳動物の幹細胞に適用することで、幹細胞の未分化状態を維持し、分化を抑制することができる。本発明に係る幹細胞の未分化状態維持剤を適用する幹細胞としては、本発明の目的に沿うものであれば特に限定されず、例えば胚性の幹細胞(ES細胞);骨髄、血液、皮膚(表皮、真皮、皮下組織)、脂肪、毛包、脳、神経、肝臓、膵臓、腎臓、筋肉やその他の組織に存在する体性の幹細胞;遺伝子導入等により人工的に作製された幹細胞(人工多能性幹細胞:iPS細胞)が挙げられるが、毛包の幹細胞に対してより効果を発揮する。本発明に係る幹細胞の未分化状態維持剤は、幹細胞の分化の方向性及び分化の過程等について同等の特性を持っていれば、全ての哺乳動物由来の幹細胞に応用が可能である。例えば、本発明に係る幹細胞の未分化状態維持剤は、ヒト、サル、マウス、ラット、モルモット、ウサギ、ネコ、イヌ、ウマ、ウシ、ヒツジ、ヤギ、ブタ等の哺乳動物の幹細胞に対して効果を発揮することができる。   The agent for maintaining undifferentiated state of stem cells of the present invention contains heat-treated and dried ginseng after steam heating treatment as an active ingredient. By applying the agent for maintaining undifferentiated state of stem cells according to the present invention to stem cells of mammals including humans, the undifferentiated state of stem cells can be maintained and differentiation can be suppressed. The stem cells to which the agent for maintaining an undifferentiated state of stem cells according to the present invention is applied are not particularly limited as long as they meet the object of the present invention, for example, embryonic stem cells (ES cells); bone marrow, blood, skin (epidermis) , Dermis, subcutaneous tissue), fat, hair follicle, brain, nerve, liver, pancreas, kidney, muscle and other tissues somatic stem cells present; stem cells artificially produced by gene transfer etc. (artificial pluripotent Stem cells (iPS cells), but exert more effect on hair follicle stem cells. The agent for maintaining the undifferentiated state of stem cells according to the present invention can be applied to all mammalian stem cells as long as they have the same characteristics with respect to the directionality of the differentiation of stem cells, the process of differentiation and the like. For example, the agent for maintaining the undifferentiated state of stem cells according to the present invention is effective against mammalian stem cells such as humans, monkeys, mice, rats, guinea pigs, rabbits, cats, dogs, horses, cattle, sheep, goats and pigs. Can be demonstrated.

本発明の好ましい態様によれば、幹細胞は毛包幹細胞であり、本発明の毛包幹細胞の未分化状態維持剤は、蒸気加熱処理後、加熱乾燥処理されたオタネニンジンを有効成分として含有し、毛包幹細胞のニッチ(幹細胞の生態的適所)である毛包内バルジ領域の毛包幹細胞の未分化状態を維持し、分化を抑制できる。   According to a preferred embodiment of the present invention, the stem cells are hair follicle stem cells, and the hair follicle stem cell undifferentiated state maintenance agent of the present invention comprises heat-treated and dried ginseng after steam heating treatment as an active ingredient, hair It can maintain the undifferentiated state of the hair follicle stem cells in the bulge region in the hair follicle that is the niche of the follicle stem cells (the ecologically appropriate place of the stem cells) and suppress the differentiation.

本発明において「毛包幹細胞の未分化状態維持」とは、毛包内バルジ領域における毛包幹細胞の未分化性の維持と機能性の維持を意味する。   In the present invention, “maintenance of the undifferentiated state of hair follicle stem cells” means maintenance of the undifferentiated nature of hair follicle stem cells and maintenance of functionality in the intra-hair follicle bulge region.

本発明において用いるオタネニンジン(学名:Panax ginseng C.A.Mey、別名:高麗人参、朝鮮人参、薬用人参)は、ウコギ科(Araliaceae)トチバニンジン属(Panax)に属する多年草で、生薬の「ニンジン」(和名:人参、学名:Ginseng Radix)の基原植物である。オタネニンジンの根を乾燥させたものが生薬として用いられているが、その製造方法の違いから、根の皮を剥ぎ、乾燥させた「白参」と、皮を付けたまま蒸して乾燥させた「紅参」に大別される。   The Panax ginseng (scientific name: Panax ginseng CAMey, aka: ginseng, ginseng, ginseng) used in the present invention is a perennial plant belonging to the genus Araliaceae, Arachiaceae (Panax). Ginseng, scientific name: Ginseng Radix) is an original plant. The dried ginseng root is used as a herbal medicine, but due to the difference in its production method, the skin of the root is peeled off and the dried "white ginseng" is steamed and dried with the skin being covered. It is divided roughly into "red ginseng".

本発明において、オタネニンジンは、その葉、茎、果実、果皮、花、花芽、種子、全草、根、根茎等の植物体の一部又は植物体全体、それらの混合物のいずれも用いることができるが、根が好ましく、根の側根部分がより好ましい。   In the present invention, ginseng can be used as part of a plant or whole plant such as its leaves, stems, fruits, peels, flowers, flower buds, seeds, whole grass, roots, rhizomes, or any mixture of them. However, the root is preferred, and the lateral root portion of the root is more preferred.

本発明においてオタネニンジンは、乾燥オタネニンジン又は生のオタネニンジンのいずれも用いることができるが、乾燥オタネニンジンが好ましい。乾燥オタネニンジンの場合、水分含量が20%以下、好ましくは10%以下となるまで乾燥させたものが好ましい。水分含量は、日本薬局方の乾燥減量などの方法を用いて測定することができる。乾燥方法としては、植物体の乾燥方法として通常用いられ、水分含量が上記の範囲となる方法であれば特に限定はされないが、例えば、自然乾燥(風乾)、天日乾燥、通風乾燥、熱風乾燥、噴霧乾燥、減圧乾燥、真空乾燥等が挙げられる。   In the present invention, as ginseng, either dried ginseng or raw ginseng can be used, but dried ginseng is preferable. In the case of dried ginseng, those dried to a water content of 20% or less, preferably 10% or less are preferable. The water content can be measured using a method such as loss on drying of the Japanese Pharmacopoeia. The drying method is not particularly limited as long as the method is usually used as a method for drying a plant and the water content is in the above range, but for example, natural drying (air drying), sun drying, ventilation drying, hot air drying , Spray drying, vacuum drying, vacuum drying and the like.

本発明において、上記の乾燥オタネニンジン又は生のオタネニンジンを抽出する前に、生薬の加工の際に行われる修治処理(蒸して乾かすという加工処理)に相当する蒸気加熱処理と加熱乾燥処理を行う。蒸気加熱処理は、熱水、飽和水蒸気、過熱蒸気、減圧(真空)蒸気等を熱媒体とし、高湿度雰囲気下、例えば、湿度80%以上の雰囲気下で対象物を加熱する処理をいう。蒸気加熱は熱媒体を対象物に直接接触させることによって行ってもよく、または対象物を熱交換機を通じて間接的に加熱してもよい。また加熱は常圧下および加圧下のいずれで行ってもよい。蒸気加熱処理の条件としては、温度は、70〜180℃が好ましく、100〜150℃がより好ましい。時間は、温度によって異なるが、1〜15時間が好ましく、2〜10時間がより好ましく、2〜6時間がさらに好ましい。これらの温度及び時間の条件はあくまで例示であり、温度及び時間の相互の関係で適宜変更できる。また、本発明における蒸気加熱処理は、連続式またはバッチ式のスチーマー(蒸し機)やオートクレーブなどを用いて行えばよい。   In the present invention, before the above-described dried ginseng or raw ginseng is extracted, steam heat treatment and heat drying treatment corresponding to a restoration treatment (processing to dry steaming) performed at the time of processing of a herbal medicine are performed. The steam heating process is a process of heating an object under a high humidity atmosphere, for example, under an atmosphere of humidity of 80% or more, using hot water, saturated steam, superheated steam, reduced pressure (vacuum) steam or the like as a heat medium. Steam heating may be performed by bringing the heat medium into direct contact with the object, or the object may be heated indirectly through a heat exchanger. The heating may be performed under normal pressure or under pressure. As conditions of steam heat processing, 70-180 ° C is preferred and 100-150 ° C is more preferred. Although time changes with temperature, 1 to 15 hours are preferable, 2 to 10 hours are more preferable, and 2 to 6 hours are further more preferable. These conditions of temperature and time are only examples and can be suitably changed by mutual relation of temperature and time. Further, the steam heat treatment in the present invention may be carried out using a continuous or batch type steamer (steamer), an autoclave or the like.

蒸気加熱処理されたオタネニンジンは、水分を含んでいるため、加熱乾燥処理を行なう。加熱乾燥の温度としては、40〜85℃が好ましく、50〜70℃がより好ましい。乾燥方法としては、通風乾燥、熱風乾燥、マイクロ波乾燥等を用いることができる。乾燥時間(加熱時間)は、加熱温度、蒸気加熱処理後のオタネニンジンの水分含量、乾燥する総量によって異なり、特定はできないが、約6〜24時間の範囲である。   Since steam-heated ginseng contains water, it is heated and dried. As temperature of heat-drying, 40-85 ° C is preferred, and 50-70 ° C is more preferred. As a drying method, ventilation drying, hot air drying, microwave drying or the like can be used. The drying time (heating time) varies depending on the heating temperature, the water content of the ginseng after steam heat treatment, and the total amount to be dried, and can not be specified, but is in the range of about 6 to 24 hours.

上記のようにして蒸気加熱処理後、加熱乾燥処理を施したオタネニンジンを抽出する。抽出方法は、特に限定されないが、水もしくは熱水、または水と有機溶媒の混合溶媒を用い、攪拌またはカラム抽出する方法により行うことができる。有機溶媒としては、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール類(1,3−ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン、流動パラフィン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。なかでも、低級アルコール、液状多価アルコール等の極性溶媒が好ましく、エタノール、1,3−ブチレングリコール、プロピレングリコール等の水溶性有機溶媒がより好ましく、これらの一種又は二種以上を用いてもよい。特に好ましい抽出溶媒としては、水、または水−エタノール系の混合極性溶媒が挙げられる。溶媒の使用量については、特に限定はなく、例えば上記オタネニンジン(乾燥重量)に対し、10倍以上、好ましくは20倍以上であればよいが、抽出後に濃縮を行なったり、単離したりする場合の操作の便宜上100倍以下であることが好ましい。また、抽出温度や時間は、用いる溶媒の種類によるが、例えば、10〜100℃、好ましくは30〜90℃で、30分〜24時間、好ましくは1〜10時間を例示することができる。また、抽出物は、抽出した溶液のまま用いてもよいが、必要に応じて、その効果に影響のない範囲で、濃縮(有機溶媒、減圧濃縮、膜濃縮などによる濃縮)、希釈、濾過、活性炭等による脱色、脱臭、エタノール沈殿等の処理を行ってから用いてもよい。さらには、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いてもよい。   After steam heat treatment as described above, the heat-treated dried ginseng is extracted. The extraction method is not particularly limited, and can be carried out by a method of stirring or column extraction using water or hot water, or a mixed solvent of water and an organic solvent. As the organic solvent, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1, 3-butylene glycol, propylene glycol, glycerin, etc.) , Ketones (acetone, methyl ethyl ketone etc.), acetonitrile, esters (ethyl acetate, butyl acetate etc.), hydrocarbons (hexane, heptane, liquid paraffin etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether etc.) Be Among them, polar solvents such as lower alcohols and liquid polyhydric alcohols are preferred, and water-soluble organic solvents such as ethanol, 1,3-butylene glycol and propylene glycol are more preferred, and one or more of these may be used. . Particularly preferred extraction solvents include water or mixed polar solvents of water-ethanol type. The amount of the solvent used is not particularly limited, and may be, for example, 10 times or more, preferably 20 times or more with respect to the above-mentioned ginseng (dry weight), but in the case of concentration or isolation after extraction For convenience of operation, it is preferably 100 times or less. Moreover, although extraction temperature and time are based on the kind of solvent to be used, they can be illustrated at, for example, 10 to 100 ° C., preferably 30 to 90 ° C., for 30 minutes to 24 hours, preferably 1 to 10 hours. In addition, the extract may be used as it is in the extracted solution, but if necessary, concentration (organic solvent, concentration by vacuum concentration, concentration by membrane concentration, etc.), dilution, filtration, to the extent that the effect is not affected. It may be used after processing such as decolorization with activated carbon, deodorization, ethanol precipitation and the like. Furthermore, the extracted solution may be subjected to treatments such as concentration to dryness, spray drying, lyophilization and the like, and used as a dried product.

上記のようにして蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物(以下、「修治オタネニンジンの抽出物」と記載する場合もある)は、生体レベルで又は培養レベルで毛包幹細胞の分化を抑制し、未分化状態を維持させる作用を有するので、毛包幹細胞の未分化状態維持剤として使用できる。また、本発明の毛包幹細胞の未分化状態維持剤は、毛包幹細胞の分化抑制剤、毛包幹細胞の機能維持剤ともいうことができる。   After steam heat treatment as described above, the extract of heat-treated ginseng (hereinafter sometimes referred to as "extract of Shuji ginseng") is differentiated at the biological level or at the culture level in hair follicle stem cell differentiation Since it has the effect | action to suppress an undifferentiated state, it can be used as an undifferentiated state maintainer of a hair follicle stem cell. In addition, the agent for maintaining the undifferentiated state of hair follicle stem cells of the present invention can also be referred to as an agent for suppressing differentiation of hair follicle stem cells or an agent for maintaining hair follicle stem cell functions.

修治オタネニンジンの抽出物は、毛包内バルジ領域の毛包幹細胞の分化抑制により、毛髪の元になる毛包幹細胞の減少又は枯渇を阻止できるとともに、毛包幹細胞における細胞外基質タンパク質の遺伝子発現を促進して毛包幹細胞周囲の細胞外環境を整えることができるので、脱毛症の予防及び/又は改善剤、細胞外基質タンパク質の遺伝子の発現促進剤の有効成分とすることができる。   The extract of the modified ginseng can inhibit the reduction or depletion of the hair follicle stem cells that are the origin of the hair by suppressing the differentiation of the hair follicle stem cells in the bulge region in the hair follicle, and the gene expression of extracellular matrix protein in the hair follicle stem cells As it can be promoted to adjust the extracellular environment around hair follicle stem cells, it can be used as an active ingredient of a hair loss preventing and / or improving agent, an expression promoting agent of extracellular matrix protein gene.

本発明において、「脱毛症の予防及び/又は改善」には、脱毛や薄毛の発生の阻止、脱毛や薄毛の程度(本数や範囲)の改善、脱毛や薄毛の進行速度の低下、脱毛や薄毛に伴う毛髪の光沢や弾性の減少の抑制などが含まれる。また、脱毛症の予防及び/又は改善効果は、頭髪に直接な作用機序を示す場合と頭部における経皮的な作用機序を示す場合の両方を含む。   In the present invention, “preventing and / or ameliorating alopecia” includes preventing hair loss and thin hair generation, improving the degree (number and range) of hair loss and thin hair, decreasing the rate of hair loss or thin hair progression, hair loss and thin hair And the reduction of the reduction of the gloss and elasticity of the hair. In addition, the preventive and / or ameliorating effect of alopecia includes both the case of showing a direct action mechanism to hair and the case of showing a percutaneous action mechanism on the head.

本発明において、脱毛症とは、例えば、加齢、疾患、紫外線や過労などの種々のストレスなどにより、毛髪の一部又は全部が抜けて、頭皮の一部又は全体が透けて見える症状をいう。脱毛症には、例えば、男性型脱毛症(AGA)、びまん性脱毛症(FAGA)、円形脱毛症、老人性脱毛症、脂漏性脱毛症、粃糠性脱毛症、産後(分娩後)脱毛症、機械性(圧迫性若しくは牽引性)脱毛症、先天性脱毛症、火傷または外傷後の脱毛症、抗がん剤による薬剤性脱毛症、瘢痕性脱毛症(毛孔性扁平苔癬、紅斑性狼瘡、禿髪性毛包炎、頭部乳頭状皮膚炎等)、トリコチロマニア(抜毛症)などが含まれるが、これらに限定はされない。   In the present invention, alopecia refers to a condition in which part or all of the hair is removed and part or all of the scalp is seen through, for example, due to aging, disease, various stress such as ultraviolet light or overwork. . Alopecia, for example, male pattern alopecia (AGA), diffuse alopecia (FAGA), alopecia areata, senile alopecia, seborrheic alopecia, epileptic alopecia, postpartum (postpartum) alopecia , Mechanical (compression or traction) alopecia, congenital alopecia, alopecia after burns or trauma, drug alopecia with anti-cancer drug, scarring alopecia There may be included, but not limited to, baldness, hair follicle folliculitis, papillary dermatitis of the head, etc.), trichotyllania (hair loss) and the like.

また、本発明の脱毛症の予防及び/又は改善剤は、そのまま使用することも可能であるが、本発明の効果を損なわない範囲で適当な添加物等と混合し、医薬品、医薬部外品、化粧品などの組成物の形態とすることができる。なかでも、頭皮や毛髪に使用するのに適した製剤形態に製剤化した毛髪用組成物が好ましい。   Moreover, the preventive and / or ameliorating agent for alopecia of the present invention can be used as it is, but it is mixed with an appropriate additive and the like within the range that does not impair the effect of the present invention. It can be in the form of a composition such as cosmetics. Among them, a hair composition formulated in a formulation suitable for use on the scalp and hair is preferred.

毛髪用組成物は、皮膚外用組成物において通常使用されている各種の成分、添加剤、基剤等をその種類に応じて選択し、適宜配合し、当分野で公知の手法に従って製造することができる。配合する成分、添加剤、基材としては、例えば、希釈剤(精製水、エタノール等)、油脂類(オリーブ油、ヤシ油、月見草油、ホホバ油、ヒマシ油、硬化ヒマシ油等)、ロウ類(ラノリン、ミツロウ、カルナウバロウ等)、炭化水素類(流動パラフィン、スクワレン、スクワラン、ワセリン等)、脂肪酸類(ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸等)、高級アルコール類(ミリスチルアルコール、セタノール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール等)、エステル類(ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オクタン酸セチル、トリオクタン酸グリセリン、ミリスチン酸オクチルドデシル、ステアリン酸オクチル、ステアリン酸ステアリル等)、有機酸類(クエン酸、乳酸、α-ヒドロキシ酢酸、ピロリドンカルボン酸等)、糖類(マルチトール、ソルビトール、キシロビオース、N-アセチル-D-グルコサミン等)、界面活性剤、シリコーン油、保湿剤、増粘剤、紫外線吸収剤、金属イオン封鎖剤、清涼化剤、抗酸化剤、安定化剤、防腐剤、消炎剤、殺菌剤、香料、着色料等が挙げられる。   The hair composition may be prepared according to methods known in the art, selecting various components, additives, bases and the like usually used in the composition for external use for skin according to the types thereof, and combining them appropriately. it can. Ingredients to be blended, additives, base materials, for example, diluents (refined water, ethanol, etc.), fats and oils (olive oil, coconut oil, evening primrose oil, jojoba oil, castor oil, hydrogenated castor oil, etc.), waxes Lanolin, beeswax, carnauba wax etc., hydrocarbons (liquid paraffin, squalene, squalane, vaseline etc.), fatty acids (lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid etc.), higher alcohols (myristyl alcohol, Setanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol etc., esters (isopropyl myristate, isopropyl palmitate, cetyl octanoate, glyceryl trioctanoate, octyldodecyl myristate, octyl stearate, stearyl stearate etc.), organic acids Citric acid, lactic acid, α-hydroxyacetic acid, pyrrolidone carboxylic acid, etc., sugars (maltitol, sorbitol, xylobiose, N-acetyl-D-glucosamine etc.), surfactant, silicone oil, moisturizer, thickener, UV light Absorbents, sequestering agents, refreshing agents, antioxidants, stabilizers, preservatives, anti-inflammatory agents, antiseptics, bactericides, fragrances, coloring agents and the like can be mentioned.

また、上記毛髪用組成物には、本発明の効果に悪影響を及ぼさない限り、育毛料・養毛料の成分として従来より知られている成分を含めてもよい。例えば、センブリエキス、柑橘類エキス等の植物抽出エキス、ビタミンB、ビタミンE及びその誘導体、ビオチン等のビタミン類、パントテン酸及びその誘導体、グリチルリチン酸及びその誘導体、ニコチン酸エステル、セリン、メチオニン等のアミノ酸類、セフォランチン、塩化カプロニウム、ミノキシジル、ニコランジル、アセチルコリン誘導体、サイクロスポリン類、及びエストラジオール等の女性ホルモン剤等、ならびにこれらの混合物が挙げられる。 In addition, the above-mentioned composition for hair may contain a component conventionally known as a component of a hair-growing agent and a hair-growing agent, as long as the effect of the present invention is not adversely affected. For example, extract of plant extract such as cerebrum extract, citrus extract, vitamin B 6 , vitamin E and derivatives thereof, vitamins such as biotin, pantothenic acid and derivatives thereof, glycyrrhizinic acid and derivatives thereof, nicotinate ester, serine, methionine, etc. Amino acids, ceforanthine, capronium chloride, minoxidil, nicorandil, acetylcholine derivatives, cyclosporins, female hormone agents such as estradiol, and the like, and mixtures thereof can be mentioned.

本発明において、毛髪用組成物は、頭皮や毛髪に使用するものを広く指し、頭皮や毛髪に適用可能なものであればいずれでもよく、剤型は特に問わない。例えば、液状、乳液状、クリーム状、ゲル状、ペースト状、スプレー状等のいずれであってもよい。具体的な製品形態としては、クリーム、ローション、乳剤、軟膏、ゲル、ヘアシャンプー、ヘアリンス、ヘアトリートメント、ヘアコンディショナー、スカルプトリートメント、ヘアスプレー、ヘアパック、ヘアエッセンス、ヘアトニック、ヘアリキッド、ヘアムースなどが挙げられる。   In the present invention, the composition for hair generally refers to those used for scalp and hair, and any composition that can be applied to scalp and hair may be used, and there is no particular limitation on the dosage form. For example, any of liquid, emulsion, cream, gel, paste, spray and the like may be used. Specific product forms include creams, lotions, emulsions, ointments, gels, hair shampoos, hair rinses, hair treatments, hair conditioners, scalp treatments, hair sprays, hair packs, hair essences, hair tonics, hair liquids, hair mousses, etc. It can be mentioned.

これらの製品形態をとる毛髪用組成物中の修治オタネニンジンの抽出物の含有量は、形態に応じて異なるので特定することはできないが、一般に、当該組成物の総重量に対し、0.0001〜20重量%(w/w)、好ましくは0.001〜10重量%(w/w)である。修治オタネニンジンの添加の方法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。   The content of the extract of modified ginseng in the composition for hair in the form of these products can not be specified because it varies depending on the form, but in general, relative to the total weight of the composition, it is from 0.0001 to It is 20% by weight (w / w), preferably 0.001 to 10% by weight (w / w). About the method of addition of Shuji ginseng, it may be added in advance or may be added during the production, and it may be appropriately selected in consideration of workability.

「細胞外基質(細胞外マトリクス)」とは、細胞の外側(細胞間)に存在する線維状や網目状の構造体をいい、細胞の形態保持や機能(増殖、分化、移動等)の制御に重要な役割を果たしている。本発明において「細胞外基質タンパク質」とは、細胞外基質を構成するタンパク質をいい、コラーゲン、フィブリリン、エラスチン、ラミニン、フィブロネクチン、テネイシン、エンタクチン、プロテオグリカン(デコリン、バーシカン、パールカン、アグリカン等)などが含まれ、より具体的には、皮膚基底膜や皮膚付属器官(毛包、汗腺、皮脂腺など)基底膜を構成するVII型コラーゲン(COL7A1)、XVII型コラーゲン(COL17A1)、ラミニン332(LAMA3,LAMB3,LAMC2)、ラミニン511(LAMA5,LAMB1,LAMC1)、デコリン等が挙げられる。   "Extracellular matrix (extracellular matrix)" refers to a fibrillar or mesh-like structure present on the outside (between cells) of cells and controls cell shape retention and function (proliferation, differentiation, migration, etc.) Play an important role. In the present invention, "extracellular matrix protein" refers to a protein constituting an extracellular matrix, and includes collagen, fibrillin, elastin, laminin, fibronectin, tenascin, entactin, proteoglycan (decorin, versican, perlecan, aggrecan, etc.) More specifically, type VII collagen (COL7A1), type XVII collagen (COL17A1), laminin 332 (LAMA3, LAMB3, etc.) constituting the basement membrane of skin basement membrane and skin appendages (hair follicle, sweat gland, sebaceous gland etc.) LAMC 2), laminin 511 (LAMA5, LAMB1, LAMC1), decorin and the like.

修治オタネニンジンの抽出物はまた、毛包幹細胞の未分化状態を維持させるための培地添加剤として利用できる。当該培地添加剤を添加した培地で培養した毛包幹細胞は、未分化性を保持しつつ、一定期間生存可能である。細胞の未分化状態維持期間は、培養目的、基礎培地の種類、培養温度などに応じて、適宜変更することができる。例えば、培地に修治オタネニンジンの抽出物を添加して通常の培養条件にて培養した場合、少なくとも1週間以上、好ましくは少なくとも2週間以上、さらに好ましくは少なくとも1ヶ月以上は、毛包幹細胞の未分化状態を維持することができる。よって、本発明はまた、毛包幹細胞を、修治オタネニンジンの抽出物を添加した培地内で培養する工程を含む、毛包幹細胞の未分化状態維持方法を提供するものである。当該方法は、例えば、毛包幹細胞の維持及び分化のメカニズム、薄毛及び/又は脱毛発生のメカニズム、抗脱毛剤の作用機序の解明に利用できる。   The extract of Shujin ginseng can also be used as a medium additive to maintain the undifferentiated state of hair follicle stem cells. Hair follicle stem cells cultured in a medium to which the medium additive has been added can survive for a certain period of time while maintaining their undifferentiated nature. The undifferentiated state maintenance period of cells can be appropriately changed according to the purpose of culture, the type of basal medium, the culture temperature and the like. For example, when an extract of Shujin ginseng is added to a culture medium and cultured under normal culture conditions, hair follicle stem cell undifferentiated at least 1 week or more, preferably at least 2 weeks or more, more preferably at least 1 month or more. It is possible to maintain the state. Thus, the present invention also provides a method for maintaining an undifferentiated state of hair follicle stem cells, which comprises the step of culturing hair follicle stem cells in a medium to which an extract of modified ginseng has been added. The method can be used, for example, to elucidate the mechanism of hair follicle stem cell maintenance and differentiation, the mechanism of thinning hair and / or hair loss, and the mechanism of action of an anti-hair loss agent.

毛包幹細胞の培養に用いる培地は、修治オタネニンジンの抽出物を添加する以外は、従来の上皮系細胞の培養に一般に用いられる基礎培地を用いることができる。例えば、毛包幹細胞の生存及び増殖に必要な成分(無機塩、炭水化物、ホルモン、必須アミノ酸、非必須アミノ酸、ビタミン、脂肪酸)を含む基本培地、例えば、Dulbecco's Modified Eagle Medium(D-MEM)、Minimum Essential Medium(MEM)、RPMI1640、Basal Medium Eagle(BME)、Ham's F12、Ham's F12K(Kaighn's modified of Ham’s F12)、Dulbecco's Modified Eagle Medium:Nutrient Mixture F-12(D-MEM/F-12)、Glasgow Minimum Essential Medium(Glasgow MEM)、ハンクス液(Hank's balanced salt solution)、MCDB153培地等が挙げられる。また、培地に、増殖因子[上皮細胞増殖因子(EGF)、コレラトキシン、塩基性線維芽細胞増殖因子(bFGF)、白血球遊走阻止因子(LIF)、Stem Cell Factor(SCF)等]、ホルモン(インスリン、ヒドロコルチゾン等)を添加することが好ましい。さらに、必要に応じて、培地は、腫瘍壊死因子(TNF)、ビタミン類、インターロイキン類、トランスフェリン、ヘパリン、ヘパラン硫酸、コラーゲン、フィブロネクチン、プロゲステロン、セレナイト、B27−サプリメント、N2−サプリメント、ITS−サプリメント、抗生物質等を含有してもよい。   As a medium used for culturing hair follicle stem cells, a basal medium generally used for culturing conventional epithelial cells can be used except for the addition of an extract of modified ginseng. For example, a basal medium containing components (inorganic salts, carbohydrates, hormones, essential amino acids, non-essential amino acids, vitamins and fatty acids) necessary for the survival and proliferation of hair follicle stem cells, such as Dulbecco's Modified Eagle Medium (D-MEM), Minimum Essential Medium (MEM), RPMI 1640, Basal Medium Eagle (BME), Ham's F12, Ham's F12 K (Kaighn's modified of Ham's F12), Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (D-MEM / F-12), Glasgow Minim Essential Medium (Glasgow MEM), Hanks' solution (Hank's balanced salt solution), MCDB 153 medium and the like can be mentioned. In addition, growth media (epithelial growth factor (EGF), cholera toxin, basic fibroblast growth factor (bFGF), leukocyte migration inhibitory factor (LIF), Stem Cell Factor (SCF), etc.) , Hydrocortisone etc.) is preferably added. Furthermore, if necessary, the medium may be tumor necrosis factor (TNF), vitamins, interleukins, transferrin, heparin, heparan sulfate, collagen, fibronectin, progesterone, selenite, B27-supplement, N2-supplement, ITS-supplement And antibiotics may be contained.

また、上記の成分以外には、0.1〜20%(v/v)の含有率でウシ脳下垂体抽出物(BPE)、血清または血清代替物が培地に含まれることが好ましい。血清または血清代替物は、公知のものであればいずれのものも用いることができる。例えば、血清としては、ウシ胎児血清(FBS、FCS)などが挙げられ、血清代替物としては、KSRなどが挙げられる。しかしながら、血清はロットの違いにより成分が異なり、その効果にバラツキがあるため、ロットチェックを行った後に使用することが好ましい。   In addition to the above components, preferably, bovine pituitary extract (BPE), serum or serum substitute is contained in the medium at a content of 0.1 to 20% (v / v). The serum or serum substitute may be any known one. For example, serum includes fetal bovine serum (FBS, FCS) and the like, and serum substitutes include KSR and the like. However, since serum has different components due to differences in lots and variations in its effects, it is preferable to use after performing lot check.

上皮系細胞の培養に必要な成分(例えば、インスリン、ヒドロコルチゾン、上皮細胞増殖因子等)を含む上皮系細胞用培地は市販されており、これらの市販品の培地を用いてもよい。例えば、Keratinocyte-SFM培地(Thermo Fisher Scientific社製)、Humedia-KG2培地(KURABO社)、CnT-PR培地(CellnTec社)、MCDB153培地(Sigma社製)、正常ヒトケラチノサイト用無血清培地(DSファーマバイオメディカル社製)等を用いることができる。   Media for epithelial cells containing components necessary for culturing epithelial cells (for example, insulin, hydrocortisone, epidermal growth factor, etc.) are commercially available, and these commercially available media may be used. For example, Keratinocyte-SFM medium (Thermo Fisher Scientific), Humedia-KG2 medium (KURABO), CnT-PR medium (CellnTec), MCDB153 medium (Sigma), serum-free medium for normal human keratinocytes (DS Pharma) Biomedical Inc.) can be used.

毛包幹細胞の培養に用いる培養器は、毛包幹細胞の培養が可能なものであれば特に限定されないが、例えば、フラスコ、シャーレ、ディッシュ、マルチウェルプレート(例えば、6ウェル、12ウェル、24ウェル、96ウェル)、チャンバースライド、チューブ、トレイ、培養バッグ、ローラーボトルなどが挙げられる。培養器の材質としては、ポリスチレン、ポリカーボネート、ポリビニルトルエン、ポリプロピレン、ポリエチレン、ポリ塩化ビニル、ナイロン、ポリメタクリレート、ゼラチン、アガロース、セルロース、ニトロセルロース、セルロースアセテート、酢酸セルロース、ポリエチレンテレフタレート等の高分子素材、ガラス、セラミックス、磁性粒子や金属等が挙げられる。   The incubator used for culturing hair follicle stem cells is not particularly limited as long as it can culture hair follicle stem cells, and, for example, flasks, petri dishes, dishes, multiwell plates (eg, 6 wells, 12 wells, 24 wells) , 96 wells), chamber slides, tubes, trays, culture bags, roller bottles and the like. As materials for the incubator, polymer materials such as polystyrene, polycarbonate, polyvinyl toluene, polypropylene, polyethylene, polyvinyl chloride, nylon, polymethacrylate, gelatin, agarose, cellulose, nitrocellulose, cellulose acetate, cellulose acetate, polyethylene terephthalate, etc. Glass, ceramics, magnetic particles, metals and the like can be mentioned.

培養器は、細胞非接着性であっても接着性であってもよく、目的に応じて適宜選択される。細胞接着性の培養器は、細胞との接着性を向上させる目的で、細胞外マトリックス等による細胞支持用基質などでコーティング処理したものを用いてもよい。細胞支持用基質としては、例えば、コラーゲン、ゼラチン、ポリ−L−リジン、ポリ−D−リジン、ラミニン、フィブロネクチンなどが挙げられる。   The incubator may be noncell-adhesive or adherent, and is appropriately selected according to the purpose. The culture vessel for cell adhesion may be one coated with a substrate for supporting cells by extracellular matrix or the like for the purpose of improving adhesion to cells. Examples of the cell support substrate include collagen, gelatin, poly-L-lysine, poly-D-lysine, laminin, fibronectin and the like.

毛包幹細胞培養に使用される培地に対する修治オタネニンジンの抽出物の添加濃度は、上述の本発明に係る毛包幹細胞の未分化状態維持剤におけるオタネニンジンの抽出物の含有量に準じて適宜決定することができるが、修治オタネニンジンの抽出物の量に換算して、例えば10〜10000μg/mL、好ましくは100〜5000μg/mLの濃度が挙げられる。また、幹細胞の培養期間中、修治オタネニンジンの抽出物を、定期的に培地に添加してもよい。   The addition concentration of the extract of modified ginseng to the culture medium used for hair follicle stem cell culture should be appropriately determined according to the content of the extract of ginseng in the undifferentiated state maintenance agent of hair follicle stem cells according to the present invention described above. The concentration is, for example, 10 to 10000 μg / mL, preferably 100 to 5000 μg / mL in terms of the amount of extract of Shuji ginseng. Also, during the stem cell culture period, extracts of modified ginseng may be periodically added to the medium.

毛包幹細胞の培養条件は、幹細胞の培養に用いられる通常の条件に従えばよく、特別な制御は必要ではない。例えば、培養温度は、特に限定されるものではないが約30〜40℃、好ましくは36〜37℃である。COガス濃度は、例えば約1〜10%、好ましくは約2〜5%である。なお、培地の交換は2〜3日に1回行うことが好ましく、毎日行うことがより好ましい。前記培養条件は、幹細胞が生存及び増殖可能な範囲で適宜変動させて設定することもできる。 The culture conditions of hair follicle stem cells may follow the usual conditions used for stem cell culture, and no special control is required. For example, the culture temperature is not particularly limited, but is about 30 to 40 ° C, preferably 36 to 37 ° C. The CO 2 gas concentration is, for example, about 1 to 10%, preferably about 2 to 5%. In addition, it is preferable to change a culture medium once every two to three days, and it is more preferable to carry out every day. The culture conditions can also be set by appropriately changing the stem cells within the viable and proliferative range.

毛包幹細胞の未分化状態維持は、例えば、本発明に係る毛包幹細胞の未分化状態維持剤の非存在下で培養した毛包幹細胞と比較して、本発明に係る毛包幹細胞の未分化状態維持剤の存在下で培養した該幹細胞において幹細胞未分化マーカー遺伝子の発現レベルがmRNAレベル又はタンパク質レベルで培養開始時の発現レベルと同程度のレベルに有意に維持されているか否かで評価することができる。毛包幹細胞未分化マーカー遺伝子としては、例えばKRT15(Keratin, type I cytoskeletal 15)等が挙げられる。   The undifferentiated state maintenance of hair follicle stem cells is, for example, compared to the hair follicle stem cells cultured in the absence of the hair follicle stem cell undifferentiated state maintenance agent according to the present invention, the undifferentiated hair follicle stem cells according to the present invention In the stem cells cultured in the presence of the state maintenance agent, the expression level of the stem cell undifferentiation marker gene is evaluated whether it is significantly maintained at the mRNA or protein level to the same level as the expression level at the start of culture. be able to. Examples of hair follicle stem cell undifferentiated marker genes include KRT15 (Keratin, type I cytoskeletal 15) and the like.

毛包幹細胞未分化マーカー遺伝子発現レベルの測定方法としては、mRNAレベルでは、例えば毛包幹細胞未分化マーカー遺伝子に特異的なプライマーやプローブを用いたRT−PCR、定量PCRやノーザンブロッティング等の方法が挙げられ、また、タンパク質レベルでは、例えば毛包幹細胞未分化マーカー遺伝子によりコードされるタンパク質に特異的な抗体を用いたELISA、フローサイトメトリー、ウエスタンブロッティング等の免疫学的方法が挙げられる。   As a method of measuring the hair follicle stem cell undifferentiated marker gene expression level, methods such as RT-PCR, quantitative PCR, northern blotting, etc. using primers and probes specific for the hair follicle stem cell undifferentiated marker gene are used at the mRNA level, for example. Also, at the protein level, for example, immunological methods such as ELISA using a specific antibody for a protein encoded by the hair follicle stem cell undifferentiated marker gene, flow cytometry, western blotting and the like can be mentioned.

発現レベルの測定の結果、培養開始時(100%未分化状態)の毛包幹細胞における毛包幹細胞未分化マーカー遺伝子の発現レベルと本発明の毛包幹細胞の未分化状態維持剤の存在下で所定時間培養後の毛包幹細胞における毛包幹細胞未分化マーカー遺伝子の発現レベルとの相対比が、本発明の毛包幹細胞の未分化状態維持剤の非存在下で培養した場合の同相対比(コントロール)よりも大きい場合に毛包幹細胞の未分化状態を維持できたと判定することができる。   As a result of measurement of the expression level, it is determined in the presence of the hair follicle stem cell undifferentiated marker gene expression level in the hair follicle stem cell at the start of culture (100% undifferentiated state) and the presence of the hair follicle stem cell undifferentiated state maintenance agent of the present invention. The relative ratio to the expression level of the hair follicle stem cell undifferentiated marker gene in hair follicle stem cells after long-term culture is the same phase contrast when cultured in the absence of the hair follicle stem cell undifferentiated state maintenance agent of the present invention (control It can be determined that the undifferentiated state of hair follicle stem cells can be maintained when the size is larger.

以下、実施例により本発明をさらに具体的に説明する。但し、本発明はこれらに限定されるものではない。   Hereinafter, the present invention will be more specifically described by way of examples. However, the present invention is not limited to these.

[実施例1] オタネニンジンの抽出物の製造例
オタネニンジンの抽出物を以下のとおり製造した。製造例2−a〜2−eは、蒸気加熱の温度を変更する以外は、製造例2と同様にして行った。
Example 1 Production Example of Extract of Panax Ginseng Extract of Panax ginseng was produced as follows. Production Examples 2-a to 2-e were carried out in the same manner as Production Example 2 except that the temperature of steam heating was changed.

(製造例1)生オタネニンジンの根(蒸気加熱:105℃、加熱乾燥:50℃)の熱水抽出物の調製
収穫後の生のオタネニンジン(水分量80%)を105℃で8時間蒸した後、50℃で乾燥させた(日本薬局方の「紅参」に適合)。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮乾固して、蒸気加熱処理(105℃)された生オタネニンジンの根の熱水抽出物17.5g得た。
Preparation Example 1 Preparation of Hot Water Extract of Raw Ginseng Root (Steam Heating: 105 ° C., Heating and Drying: 50 ° C.) After steaming of freshly harvested ginseng (water content 80%) after harvest at 105 ° C. for 8 hours And dried at 50 ° C. (compatible with the Japanese Pharmacopoeia "red ginseng"). 800 mL of purified water is added to 40 g of the dried ginseng, and extracted for 2 hours at 95-100 ° C., followed by filtration, the filtrate is concentrated to dryness, and the steam heat treatment (105 ° C.) of fresh ginseng root 17.5 g of hot water extract was obtained.

(製造例2)乾燥オタネニンジンの根(蒸気加熱:105℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を105℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(105℃)された乾燥オタネニンジンの根の熱水抽出物18.7g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 105 ° C., Heat Drying: 50 ° C.) After steaming dried Ginseng root (water content 9%) at 105 ° C. for 8 hours, It was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted for 2 hours at 95-100 ° C., followed by filtration, and the filtrate is concentrated, lyophilized and steam-heated (105 ° C.) dried ginseng root 18.7 g of a hot water extract of

(製造例3)乾燥オタネニンジンの根(蒸気加熱:105℃、加熱乾燥:70℃)の50%エタノール抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を105℃で8時間蒸した後、70℃で乾燥させた。このオタネニンジンの乾燥物100gに精製水500mL及びエタノール500mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、蒸気加熱処理(105℃)された乾燥オタネニンジンの根の50%エタノール抽出物43g得た。
Preparation Example 3 Preparation of 50% ethanolic extract of dried ginseng root (vapor heating: 105 ° C., heating and drying: 70 ° C.) After steaming dried ginseng root (water content 9%) at 105 ° C. for 8 hours And dried at 70 ° C. After adding 500 mL of purified water and 500 mL of ethanol to 100 g of the dried ginseng, and extracting for 7 days at room temperature, the filtrate is concentrated to dryness and steam heated (105 ° C.) of dried ginseng root 43 g of 50% ethanol extract was obtained.

(製造例4)乾燥オタネニンジンの葉及び茎(蒸気加熱:100℃、加熱乾燥:60℃)の1,3−ブチレングリコール抽出物の調製
乾燥したオタネニンジンの葉及び茎(水分量10%)を100℃で4時間蒸した後、60℃で乾燥させた。このオタネニンジンの乾燥物20gに1,3−ブチレングリコール200mLを加え、常温で7日間抽出した後、濾過し、蒸気加熱処理(100℃)された乾燥オタネニンジンの葉及び茎の1,3−ブチレングリコール抽出物141g得た。
Preparation Example 4 Preparation of 1,3-Butylene Glycol Extract of Dried Panax ginseng Leaves and Stems (Steam Heating: 100 ° C., Heating and Drying: 60 ° C.) 100 Dried Panax Ginseng Leaves and Stems (10% Water Content) After steaming at 4 ° C for 4 hours, it was dried at 60 ° C. 200 mL of 1,3-butylene glycol is added to 20 g of the dried ginseng, and extracted for 7 days at room temperature, followed by filtration and steam heating (100 ° C.) of dried ginseng leaves and stems of 1,3-butylene glycol 141 g of extract was obtained.

(比較製造例1)生オタネニンジンの根(蒸気加熱処理なし)の熱水抽出物の調製
収穫後の生のオタネニンジンの根を65℃で乾燥させたもの40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥してオタネニンジンの根の熱水抽出物を12.5g得た。
(Comparative Production Example 1) Preparation of hot water extract of fresh ginseng root (without steam heating treatment) 800 mL of purified water is added to 40 g of dried fresh ginseng root after harvest at 65 ° C., and 95 to 100 After 2 hours of extraction at ° C., the filtrate was concentrated and lyophilized to give 12.5 g of a hot water extract of Ginseng root.

(比較製造例2)生オタネニンジンの根(蒸気加熱処理なし)の50%エタノール抽出物の調製
収穫後の生のオタネニンジンの根を65℃で乾燥させたもの100gに精製水500mL及びエタノール500mLを加え、常温で7日間抽出した後、濾過し、その濾液を濃縮乾固して、オタネニンジンの根の50%エタノール抽出物を15.1g得た。
Comparative Preparation Example 2 Preparation of 50% Ethanol Extract of Raw Ginseng Root (Without Steam Heating Treatment) 500 mL of purified water and 500 mL of ethanol were added to 100 g of dried ginseng root after harvest at 65 ° C. After 7 days of extraction at room temperature, the filtrate was concentrated to dryness to obtain 15.1 g of a 50% ethanol extract of Ginseng roots.

(製造例2−a)乾燥オタネニンジンの根(蒸気加熱:70℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を70℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(70℃)された乾燥オタネニンジンの根の熱水抽出物17.2g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 70 ° C., Heated Drying: 50 ° C.) Dried ginseng root (water content 9%) was steamed at 70 ° C. for 8 hours Thereafter, it was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted at 95-100 ° C. for 2 hours, followed by filtration, the filtrate is concentrated, lyophilized and steam-heated (70 ° C.) dried ginseng root 17.2 g of a hot water extract of

(製造例2−b)乾燥オタネニンジンの根(蒸気加熱:100℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を100℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(100℃)された乾燥オタネニンジンの根の熱水抽出物18.1g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 100 ° C., Heat Drying: 50 ° C.) Dried ginseng root (water content 9%) was steamed at 100 ° C. for 8 hours Thereafter, it was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted at 95-100 ° C. for 2 hours, followed by filtration, the filtrate is concentrated, lyophilized, and steam-heated (100 ° C.) dried ginseng root 18.1 g of a hot water extract of

(製造例2−c)乾燥オタネニンジンの根(蒸気加熱:121℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量7%)を121℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(121℃)された乾燥オタネニンジンの根の熱水抽出物17.6g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 121 ° C., Heated Drying: 50 ° C.) Dried ginseng root (water content 7%) was steamed at 121 ° C. for 8 hours Thereafter, it was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted at 95-100 ° C. for 2 hours, followed by filtration, the filtrate is concentrated, freeze-dried and steam-heated (121 ° C.) dried ginseng root 17.6 g of a hot water extract of

(製造例2−d)乾燥オタネニンジンの根(蒸気加熱:150℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を150℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(150℃)された乾燥オタネニンジンの根の熱水抽出物19.0g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 150 ° C., Heated Drying: 50 ° C.) Dried ginseng root (water content 9%) was steamed at 150 ° C. for 8 hours Thereafter, it was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted for 2 hours at 95-100 ° C., followed by filtration, the filtrate is concentrated, freeze-dried and steam-heated (150 ° C.) dried ginseng root 19.0 g of a hot water extract of

(製造例2−e)乾燥オタネニンジンの根(蒸気加熱:180℃、加熱乾燥:50℃)の熱水抽出物の調製
乾燥したオタネニンジンの根(水分量9%)を180℃で8時間蒸した後、50℃で乾燥させた。このオタネニンジンの乾燥物40gに精製水800mLを加え、95〜100℃で2時間抽出した後、濾過し、その濾液を濃縮し、凍結乾燥して蒸気加熱処理(180℃)された乾燥オタネニンジンの根の熱水抽出物18.6g得た。
Preparation Example 2 Preparation of Hot Water Extract of Dried Ginseng Root (Steam Heating: 180 ° C., Heated Drying: 50 ° C.) Dried ginseng root (water content 9%) was steamed at 180 ° C. for 8 hours Thereafter, it was dried at 50 ° C. 800 mL of purified water is added to 40 g of the dried ginseng, and extracted for 2 hours at 95-100 ° C., followed by filtration, the filtrate is concentrated, lyophilized and steam-heated (180 ° C.) dried ginseng root 18.6 g of a hot water extract of

[実施例2]オタネニンジンの抽出物の毛包幹細胞に対する未分化状態維持効果及び細胞外基質遺伝子の発現促進効果の評価
実施例1において製造したオタネニンジンの各抽出物を用いて毛包幹細胞に対する未分化性維持状態効果及び細胞外基質タンパク質の遺伝子(以下、「細胞外基質遺伝子」という)の発現促進効果の評価を行った。
[Example 2] Evaluation of maintenance effect of undifferentiated state on hair follicle stem cells of extract of Panax ginseng and expression promoting effect of extracellular matrix gene Undifferentiation of hair follicle stem cells using each extract of Panax ginseng prepared in Example 1 The evaluation of the sex maintenance state effect and the expression promoting effect of the extracellular matrix protein gene (hereinafter referred to as "the extracellular matrix gene") was performed.

(実験例1)毛包幹細胞に対する未分化状態維持効果の評価
(1)ヒト毛包幹細胞の培養
ヒトの毛髪を毛抜きで採取し、メス等を用いて毛包組織のバルジ領域を含む組織を回収した。PBS(-)にて洗浄した後、トリプシン(BD Biosciences社製)処理を行った。その後、セルストレイナー(FALCON社製)を用いて、細胞を単離し、回収した。回収した細胞を培養プレートに播種し、KG2培地(KURABO社製)を用いてコンフルエントになるまで維持した。コンフルエントになった細胞を回収し、同培養プレートに再び播種し、その後生着し、増殖している細胞を毛包幹細胞として以下の試験に用いた。
(Experimental Example 1) Evaluation of maintenance effect of undifferentiated state on hair follicle stem cells (1) Culture of human hair follicle stem cells Human hair is collected by tweezers and tissues including bulge region of hair follicle tissue are collected using a female etc. did. After washing with PBS (−), treatment with trypsin (manufactured by BD Biosciences) was performed. Thereafter, cells were isolated and recovered using Cell Trainer (manufactured by FALCON). The recovered cells were seeded on a culture plate, and maintained until confluence using KG2 medium (manufactured by KURABO). Confluent cells were collected and replated on the same culture plate, and then engrafted and proliferated cells were used as hair follicle stem cells in the following test.

(2)オタネニンジンの抽出物を添加した際の毛包幹細胞の未分化性の評価
毛包幹細胞にオタネニンジンの抽出物を作用させ、オタネニンジンの抽出物が毛包幹細胞の未分化性にどのように関わっているかを評価した。未分化性は、KG2培地(KURABO社製)にて培養した毛包幹細胞を24ウェルの培養プレートに1×10個ずつ播種し、オタネニンジンの抽出物(製造例1〜4、製造例2−a〜2−e、比較製造例1〜2)を最終濃度が100 μg/mlとなるように添加して培養し、オタネニンジンの抽出物の添加48時間後の毛包幹細胞を回収し、毛包幹細胞の未分化性をKRT15(Keratin, type I cytoskeletal 15)の遺伝子発現量を指標に解析した。
(2) Evaluation of the undifferentiated nature of hair follicle stem cells when adding ginseng extract The extract of ginseng is caused to act on hair follicle stem cells, and the extract of ginseng affects how undifferentiated of hair follicle stem cells It was evaluated. For undifferentiated cells, 1 × 10 4 hair follicle stem cells cultured in KG2 medium (manufactured by KURABO) are seeded on a 24-well culture plate, and the extract of Panax ginseng (Production Example 1 to 4, Production Example 2-2 a to 2-e, Comparative Production Examples 1 and 2) are added and cultured so that the final concentration is 100 μg / ml, hair follicle stem cells are collected 48 hours after addition of the extract of Ginseng, and hair follicles The undifferentiated nature of stem cells was analyzed using the gene expression level of KRT15 (Keratin, type I cytoskeletal 15) as an index.

KRT15の遺伝子発現解析は次の通り行った。オタネニンジンの抽出物添加後の毛包幹細胞をPBS(-)にて2回洗浄した後、Trizol Reagent(Invitrogen社製)によって該細胞からRNAを抽出した。2-STEPリアルタイムPCRキット(Applied Biosystems社製)を用いて、抽出したRNAをcDNAに逆転写した後、ABI7300(Applied Biosystems社製)により、下記プライマーセットを用いてリアルタイムPCR(95℃:15秒間、60℃:30秒間、40cycles)を実施し、KRT15の遺伝子発現量を測定した。その他の操作は定められた方法に従って実施した。   The gene expression analysis of KRT15 was performed as follows. Hair follicle stem cells after addition of a ginseng extract were washed twice with PBS (−), and RNA was extracted from the cells with Trizol Reagent (manufactured by Invitrogen). After reverse transcription of the extracted RNA to cDNA using a 2-STEP real time PCR kit (manufactured by Applied Biosystems), real time PCR (95 ° C: 15 seconds) using the following primer set by ABI 7300 (manufactured by Applied Biosystems) At 60 ° C. for 30 seconds, and 40 cycles were performed, and the gene expression level of KRT15 was measured. Other operations were carried out according to the prescribed method.

KRT15(毛包幹細胞未分化マーカー)用プライマーセット:
5'- GATGCTGCTTGACATAAAGACACG-3' (配列番号1)
5'- ACCTGTCCATCCACTGACTCTTC-3' (配列番号2)
18srRNA(内部標準)用プライマーセット:
5'-CCGAGCCGCCTGGATAC-3' (配列番号3)
5'-CAGTTCCGAAAACCAACAAAATAGA-3'(配列番号4)
Primer set for KRT15 (hair follicle stem cell undifferentiated marker):
5'- GATGCTGCTTGACATAAAGACAG-3 '(SEQ ID NO: 1)
5'- ACCTG TCC ATCC ACT GACT CT TC-3 '(SEQ ID NO: 2)
Primer set for 18srRNA (internal standard):
5'-CCGAGCCCGCCTGGATAC-3 '(SEQ ID NO: 3)
5'-CAGTTCCGAAAACCAACAAAATAGA-3 '(SEQ ID NO: 4)

毛包幹細胞の未分化状態維持効果は、オタネニンジンの抽出物を添加せずに培養した毛包幹細胞におけるKRT15のmRNAの発現量を内部標準である18s ribosomal RNA(18srRNA)の発現量に対する割合として算出したKRT15遺伝子相対発現量(KRT15遺伝子発現量/18srRNA遺伝子発現量)の値を1とし、これに対し、オタネニンジンの抽出物を添加して培養した毛包幹細胞におけるKRT15の遺伝子相対発現量の値を算出し、評価した。結果を以下の表1及び表2に示す。   The undifferentiated state maintenance effect of hair follicle stem cells is calculated by expressing the expression level of KRT15 mRNA in hair follicle stem cells cultured without adding ginseng extract as a percentage of the expression level of 18s ribosomal RNA (18srRNA) as an internal standard. The value of the KRT15 gene relative expression level (KRT15 gene expression level / 18srRNA gene expression level) is 1, and the value of the gene relative expression level of KRT15 in hair follicle stem cells cultured by adding the extract of Ginseng Calculated and evaluated. The results are shown in Tables 1 and 2 below.

Figure 2019094268
Figure 2019094268

Figure 2019094268
Figure 2019094268

表1に示すように、蒸気加熱処理後、加熱乾燥処理を行ったオタネニンジンの抽出物(製造例1〜4)を添加した培地で培養した毛包幹細胞では、蒸気加熱処理を行っていないオタネニンジンの抽出物(比較製造例1〜2)に比べて、未分化マーカーKRT15の発現が著しく上昇し、優れた毛包幹細胞の未分化維持効果を有することが示された。また、蒸気加熱処理前に乾燥させたオタネニンジン(製造例2〜4)を用いたほうが、生のオタネニンジン(製造例1)を用いるよりも当該効果が高かった。また、表2に示すように、蒸気加熱処理の温度が100〜150℃の範囲で、特に毛包幹細胞の未分化維持効果が顕著であった(製造例2−b、2−c、2−d)。   As shown in Table 1, hair follicle stem cells cultured in a medium to which the extract of Panax ginseng (Production Examples 1 to 4) subjected to heating and drying was added after steam heating was used. Compared with the extracts (Comparative Production Examples 1 and 2), the expression of the undifferentiated marker KRT15 was significantly increased, and it was shown to have an excellent undifferentiated maintenance effect of hair follicle stem cells. Moreover, the said effect was higher when using ginseng (Product Examples 2 to 4) dried before the steam heat treatment than using raw ginseng (Product Example 1). In addition, as shown in Table 2, the undifferentiated maintenance effect of hair follicle stem cells was particularly remarkable when the temperature of steam heat treatment was in the range of 100 to 150 ° C. (Production Example 2-b, 2-c, 2- d).

(実験例2)オタネニンジン抽出物の細胞外基質遺伝子の発現促進効果
(1)ヒト毛包幹細胞の培養
ヒトの毛髪を毛抜きで採取し、メス等を用いて毛包組織のバルジ領域を含む組織を回収した。PBS(-)にて洗浄した後、トリプシン(BD Biosciences社製)処理を行った。その後、セルストレイナー(FALCON社製)を用いて、細胞を単離し、回収した。回収した細胞を培養プレートに播種し、KG2培地(KURABO社製)を用いてコンフルエントになるまで維持した。コンフルエントになった細胞を回収し、培養プレートに再び播種し、その後生着し、増殖している細胞を毛包幹細胞として以下の試験に用いた。
(Experimental Example 2) Expression promoting effect of extracellular matrix gene of Ginseng extract (1) Culture of human hair follicle stem cells Human hair is collected by tweezers and tissue including bulge region of hair follicle tissue is obtained using a female etc. It was collected. After washing with PBS (−), treatment with trypsin (manufactured by BD Biosciences) was performed. Thereafter, cells were isolated and recovered using Cell Trainer (manufactured by FALCON). The recovered cells were seeded on a culture plate, and maintained until confluence using KG2 medium (manufactured by KURABO). Confluent cells were collected and replated on culture plates, and then engrafted and proliferated cells were used as hair follicle stem cells in the following tests.

(2)オタネニンジン抽出物を添加した際の細胞外基質遺伝子の発現量の評価
毛包幹細胞にオタネニンジンの抽出物を作用させ、オタネニンジンの抽出物が毛包幹細胞における細胞外基質遺伝子の発現にどのように関わっているかを評価した。
(2) Evaluation of the expression level of extracellular matrix gene when adding ginseng extract The extract of ginseng is made to act on hair follicle stem cells and how the extract of ginseng is related to the expression of extracellular matrix gene in hair follicle stem cells It was evaluated whether it was related to

試験は次の通り行った。毛包幹細胞に対してオタネニンジンの抽出物(製造例1〜4、比較製造例1〜2)を最終濃度が100 μg/mlとなるように添加した。オタネニンジンの抽出物を添加して、48時間後の細胞を回収し、毛包幹細胞の細胞外基質遺伝子発現量をCOL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMA5, LAMB1, LAMC1, DCNの遺伝子発現量を指標として解析した。   The test was performed as follows. Extracts of Panax ginseng (Production Examples 1 to 4; Comparative Production Examples 1 and 2) were added to hair follicle stem cells to a final concentration of 100 μg / ml. Extract of Panax ginseng added, cells after 48 hours were collected, extracellular matrix gene expression levels of hair follicle stem cells were expressed as COL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMC2, LAMA5, LAMB1, LAMC1, DCN Was analyzed as an index.

遺伝子発現解析は次の通り行った。オタネニンジンの抽出物添加後の毛包幹細胞をPBS(-)にて2回洗浄した後、Trizol Reagent(Invitrogen社製)によって細胞からRNAを抽出した。2-STEPリアルタイムPCRキット(Applied Biosystems社製)を用いて、抽出したRNAをcDNAに逆転写した後、ABI7300(Applied Biosystems社製)により、リアルタイムPCR(95℃:15秒間、60℃:30秒間、40cycles)を実施し、COL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMA5, LAMB1, LAMC1, DCNの遺伝子発現量を測定した。その他の操作は定められた方法に従って実施した。   Gene expression analysis was performed as follows. The hair follicle stem cells after addition of the extract of Panax ginseng were washed twice with PBS (−), and then RNA was extracted from the cells with Trizol Reagent (manufactured by Invitrogen). After reverse transcription of the extracted RNA into cDNA using a 2-STEP real time PCR kit (manufactured by Applied Biosystems), real time PCR (95 ° C .: 15 seconds, 60 ° C .: 30 seconds) by ABI 7300 (manufactured by Applied Biosystems) 40 cycles, and the gene expression levels of COL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMC5, LAMB1, LAMC1, DCN were measured. Other operations were carried out according to the prescribed method.

COL7A1用プライマーセット:
5'-CACTGGAGCCACAGCTTACA-3' (配列番号5)
5'-GCTGACTCCACCTTCGAGAC-3' (配列番号6)
COL17A1用プライマーセット:
5'-TCCTGTCCAACTCAGAAACC-3' (配列番号7)
5'-ACCTGGATCACCTTTGTCAC-3' (配列番号8)
LAMA3用プライマーセット:
5'-AACCAAAAAGTGCTCGGAAGAC-3' (配列番号9)
5'-TCAGTAGGTGGTAAGCCCAAATC-3' (配列番号10)
LAMB3用プライマーセット:
5'-GGGAGACCCCCACATTCAA-3' (配列番号11)
5'-GCTGTGTGTTCTGCCGTTCTT-3' (配列番号12)
LAMC2用プライマーセット:
5'-GGATGAGAATCCTGACATTGAGTGT-3' (配列番号13)
5'-GTCGTGCGGATCGTTGTAGA-3' (配列番号14)
LAMA5用プライマーセット:
5'-CAGCACTGCACTAGAAGAGG-3' (配列番号15)
5'-CTTGCTTGTCTCGTCTGTGTC-3' (配列番号16)
LAMB1用プライマーセット:
5'-ATCCCAAAGTTCTCAAGTCCT-3' (配列番号17)
5'-GTCCATTACATTTACATCTGCCAC-3' (配列番号18)
LAMC1用プライマーセット:
5'-CTTCTGTCTGTACAAACGCTG-3' (配列番号19)
5'-CCATCCTCATCAATCTGAAAGG-3' (配列番号20)
DCN用プライマーセット:
5'-TTCTGCCCACCTGGACACA-3' (配列番号21)
5'-GACCGGGTTGCTGAAAAGAC-3' (配列番号22)
18srRNA(内部標準)用プライマーセット:
5'-CCGAGCCGCCTGGATAC-3' (配列番号3)
5'-CAGTTCCGAAAACCAACAAAATAGA-3'(配列番号4)
Primer set for COL7A1:
5'-CACTGGAGCCACAGCTTACA-3 '(SEQ ID NO: 5)
5'-GCTGACTCCACCTTCGAGAC-3 '(SEQ ID NO: 6)
Primer set for COL17A1:
5'-TCCTGTCCAACTCAGAAACC-3 '(SEQ ID NO: 7)
5'-ACCTGGATCACCTTTGTCAC-3 '(SEQ ID NO: 8)
Primer set for LAMA3:
5'-AACCAAAAGTGCTCGGAGAC-3 '(SEQ ID NO: 9)
5'-TCAGTAGGTGGTAAGCCCAAATC-3 '(SEQ ID NO: 10)
Primer set for LAMB3:
5'- GGGAGACCCCCACATTCAA-3 '(SEQ ID NO: 11)
5'-GCTGTGTGTTCTGCTCGTTCTT-3 '(SEQ ID NO: 12)
Primer set for LAMC2:
5'-GGATGAGAATCCTGACATTGAGTGT-3 '(SEQ ID NO: 13)
5'-GTCGTGCGGATCGTTGTAGA-3 '(sequence number 14)
Primer set for LAMA5:
5'-CAGCACTGCACTAGAAGAGG-3 '(SEQ ID NO: 15)
5'-CTTGCTTGTCTCGTCTTGTGTC-3 '(SEQ ID NO: 16)
Primer set for LAMB1:
5'-ATCC CAAAGTTCTCAAGTCCT-3 '(SEQ ID NO: 17)
5'-GTCCATTACATTTACATCTGCCCAC-3 '(SEQ ID NO: 18)
Primer set for LAMC1:
5'-CTTCTGTCTGTACAAAACGCTG-3 '(SEQ ID NO: 19)
5'-CCATCCTTCATCAATCTGAAAGG-3 '(SEQ ID NO: 20)
Primer set for DCN:
5'-TTCTGCCCACCTGGACACA-3 '(SEQ ID NO: 21)
5'-GACCGGGTTGCTGAAAAGAC-3 '(SEQ ID NO: 22)
Primer set for 18srRNA (internal standard):
5'-CCGAGCCCGCCTGGATAC-3 '(SEQ ID NO: 3)
5'-CAGTTCCGAAAACCAACAAAATAGA-3 '(SEQ ID NO: 4)

細胞外基質遺伝子(以下、「標的遺伝子」という)の発現は、オタネニンジンの抽出物を添加せずに培養した毛包幹細胞における各標的遺伝子のmRNAの発現量を内部標準である18s ribosomal RNA(18srRNA)の発現量に対する割合として算出した標的遺伝子相対発現量(標的遺伝子発現量/18srRNA遺伝子発現量)の値を1とし、これに対し、オタネニンジンの抽出物を添加して培養した毛包幹細胞の各標的遺伝子相対発現量の値を算出し、評価した。結果を以下の表3に示す。   The expression of extracellular matrix gene (hereinafter referred to as "target gene") is 18s ribosomal RNA (18srRNA), which is an internal standard for the expression level of mRNA of each target gene in hair follicle stem cells cultured without adding ginseng extract Each value of target gene relative expression level (target gene expression level / 18srRNA gene expression level) calculated as a ratio to expression level of 1) is 1, and each of hair follicle stem cells cultured by adding extract of Panax ginseng The value of the target gene relative expression level was calculated and evaluated. The results are shown in Table 3 below.

Figure 2019094268
Figure 2019094268

表3に示すように、蒸気加熱処理後、加熱乾燥処理を行ったオタネニンジンの抽出物(製造例1〜4)を添加した培地で培養した毛包幹細胞では、蒸気加熱処理を行っていないオタネニンジンの抽出物(比較製造例1〜2)に比べて、COL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMA5, LAMB1, LAMC1, DCNの発現量が高く、優れた細胞外基質遺伝子の発現促進効果が示された。また、蒸気加熱処理前に乾燥させたオタネニンジン(製造例2〜4)を用いたほうが、生のオタネニンジン(製造例1)を用いるよりも当該効果が高かった。   As shown in Table 3, hair follicle stem cells cultured in a medium to which the extract of Panax ginseng (Production Examples 1 to 4) subjected to heating and drying was added after steam heating was used. Compared with the extracts (Comparative Production Examples 1 and 2), the expression levels of COL7A1, COL17A1, LAMA3, LAMB3, LAMC2, LAMC2, LAMA5, LAMB1, LAMC1, DCN are higher, showing an excellent expression promoting effect on extracellular matrix genes The Moreover, the said effect was higher when using ginseng (Product Examples 2 to 4) dried before the steam heat treatment than using raw ginseng (Product Example 1).

本発明は、脱毛症の予防及び/又は改善を目的とした医薬品、医薬部外品、又は化粧品の製造分野において利用できる。   The present invention can be used in the field of manufacturing medicines, quasi-drugs or cosmetics intended for the prevention and / or amelioration of alopecia.

Claims (6)

蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、幹細胞の未分化状態維持剤。   An agent for maintaining an undifferentiated state of stem cells, comprising an extract of heat-dried processed ginseng as an active ingredient after steam heat treatment. 前記幹細胞が、毛包幹細胞である、請求項1に記載の幹細胞の未分化状態維持剤。   The agent for maintaining the undifferentiated state of stem cells according to claim 1, wherein the stem cells are hair follicle stem cells. 蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、脱毛症の予防及び/又は改善剤。   An agent for the prevention and / or amelioration of alopecia, which comprises an extract of heat-dried treated ginseng as an active ingredient after steam heat treatment. 蒸気加熱処理後、加熱乾燥処理されたオタネニンジンの抽出物を有効成分として含有することを特徴とする、細胞外基質タンパク質の遺伝子の発現促進剤。   An expression promoter for an extracellular matrix protein gene, which comprises as an active ingredient an extract of heat-dried ginseng after steam heat treatment. 前記オタネニンジンが、乾燥又は生のオタネニンジンである、請求項1〜4のいずれか1項に記載の剤。   The agent according to any one of claims 1 to 4, wherein the ginseng is dried or raw ginseng. 請求項3に記載の脱毛症の予防及び/又は改善剤を含む、毛髪用組成物。   A hair composition comprising the agent for preventing and / or ameliorating alopecia according to claim 3.
JP2017222047A 2017-11-17 2017-11-17 Hair follicle stem cell undifferentiated state maintainer Active JP7089267B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017222047A JP7089267B2 (en) 2017-11-17 2017-11-17 Hair follicle stem cell undifferentiated state maintainer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017222047A JP7089267B2 (en) 2017-11-17 2017-11-17 Hair follicle stem cell undifferentiated state maintainer

Publications (2)

Publication Number Publication Date
JP2019094268A true JP2019094268A (en) 2019-06-20
JP7089267B2 JP7089267B2 (en) 2022-06-22

Family

ID=66970908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017222047A Active JP7089267B2 (en) 2017-11-17 2017-11-17 Hair follicle stem cell undifferentiated state maintainer

Country Status (1)

Country Link
JP (1) JP7089267B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021095370A (en) * 2019-12-18 2021-06-24 日本メナード化粧品株式会社 Panax ginseng seeds treated by method comprising steam heat treatment step and/or skin external or internal formulation containing extract thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238365A (en) * 2002-02-19 2003-08-27 Shiseido Co Ltd Hair grower
KR20170094632A (en) * 2016-02-11 2017-08-21 대전대학교 산학협력단 Manufacturing method for hair loss prevention shampoos containing ginsenoside Rg2

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238365A (en) * 2002-02-19 2003-08-27 Shiseido Co Ltd Hair grower
KR20170094632A (en) * 2016-02-11 2017-08-21 대전대학교 산학협력단 Manufacturing method for hair loss prevention shampoos containing ginsenoside Rg2

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CURRENT STEM CELL REPORTS, vol. 2, JPN6021039350, 2016, pages 197 - 206, ISSN: 0004612745 *
JOURNAL OF MEDICAL FOOD, vol. 18(3), JPN6021039353, 2015, pages 354 - 362, ISSN: 0004612743 *
生化学, vol. 80(7), JPN6021039351, 2008, pages 638 - 641, ISSN: 0004612744 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021095370A (en) * 2019-12-18 2021-06-24 日本メナード化粧品株式会社 Panax ginseng seeds treated by method comprising steam heat treatment step and/or skin external or internal formulation containing extract thereof

Also Published As

Publication number Publication date
JP7089267B2 (en) 2022-06-22

Similar Documents

Publication Publication Date Title
US10251824B2 (en) Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method
JP6535505B2 (en) An agent for maintaining undifferentiated state of stem cells and an agent for promoting proliferation using the extract of Mannengtake mushroom
JP7082788B2 (en) Hair follicle cell activator
JP6843425B2 (en) Stem cell undifferentiated state maintainer and growth promoter
JP7089267B2 (en) Hair follicle stem cell undifferentiated state maintainer
JP6583679B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter using yeast extract
JP6159183B2 (en) Stem cell-derived growth factor production promoter
JP6697252B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP6571494B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter using Ainu Wakame
JP6411778B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP6587899B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP6649050B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP2013194001A (en) Promotor for inducing melanocyte differentiation
JP6200713B2 (en) Stem cell-derived growth factor production promoter
JP7214191B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP7202610B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
JP7178087B2 (en) Stem cell undifferentiated state maintenance agent and growth promoter
KR20150087047A (en) Serum-free medium composition for stem cell culture and methods for culturing stem cell
JP5993299B2 (en) Melanocyte differentiation induction promoter and method of using the same
JP2019210245A (en) CXCL12 expression promoter
JP7205880B2 (en) MELANOCYTE DIFFERENTIATION INDUCTIVE AND USAGE THEREOF
JP5902442B2 (en) Melanocyte differentiation induction promoter and method of using the same
JP6200714B2 (en) Stem cell-derived growth factor production promoter
JP6763604B2 (en) Stem cell undifferentiated state maintainer and growth promoter
JP2024038890A (en) Function enhancer for exosome

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211206

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220425

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220425

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220510

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220517

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220531

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220603

R150 Certificate of patent or registration of utility model

Ref document number: 7089267

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150